TG Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.4% | +13.3% | +7.5% | +46.1% | -1.4% | +13.7% | +7.0% | +45.9% | +3.7% | +43.8% | +7.2% | |
| – | -0.4% | +13.4% | +7.9% | +47.5% | -1.3% | +13.8% | +3.0% | -9.7% | +5.2% | +72.3% | +5.4% | |
| – | -38.4% | -18.8% | +9.8% | +136.2% | -8.1% | -26.5% | -2.3% | -42.6% | +6.8% | +458.7% | +9.1% | |
| – | -5.1% | -3.6% | +3.6% | +57.0% | -8.8% | -11.2% | -8.8% | -47.8% | +7.9% | +262.4% | +7.4% | |
| – | +29.9% | +27.2% | +28.7% | +38.4% | +11.6% | +47.2% | +21.8% | +14.6% | +15.2% | +28.3% | +2.4% | |
| – | +18.7% | +95.2% | +4.5% | +4.2% | +30.5% | +42.8% | -1.6% | -5.3% | -14.5% | +2.7% | +14.7% | |
| – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | +1.7% | +26.1% | +4.9% | +76.1% | -9.8% | +18.0% | +1.6% | -2.0% | -0.6% | +127.8% | +9.5% | |
| – | -6.9% | +85.6% | +9.0% | +15.1% | -27.5% | +76.7% | +7.3% | -8.8% | -1.9% | +21.7% | +43.5% | |
| – | -2.2% | -4.4% | -5.6% | -5.7% | -6.0% | -3.5% | -2.2% | +73.4% | -44.8% | +74.5% | +5.0% | |
| – | -3.2% | +126.8% | +7.1% | +8.5% | -42.5% | +129.7% | +0.1% | -16.2% | -4.3% | +38.5% | +43.6% | |
| – | +1.2% | +1.2% | +1.2% | +138.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +203.3% | +0.0% | |
| – | -2.6% | -0.2% | +10.9% | +8.2% | +15.7% | +6.7% | +16.5% | +119.7% | +6.7% | -10.0% | +3.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -8.2% | +2.2% | +9.0% | +0.8% | -0.3% | +1.6% | -0.1% | -1.0% | -1.0% | +0.4% | -1.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.